Evidence map›Paper›PMID 12097504›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2002

Targeted disruption of RC3 reveals a calmodulin-based mechanism for regulating metaplasticity in the hippocampus.

Thomas Krucker, George R Siggins, Robert K McNamara, Kristen A Lindsley, Alan Dao, David W Allison, Luis De Lecea, Timothy W Lovenberg, J Gregor Sutcliffe, Dan D Gerendasy

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 97 citations in OpenAlex.

  1. Neurogranin Promotes Neuronal Maturation and Network Activity Through CaInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Neurogranin Regulates Metaplasticity.Frontiers in molecular neuroscience · 2019
    Article
  13. Competitive Tuning Among CaCellular and molecular bioengineering · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Increased prefrontal cortex neurogranin enhances plasticity and extinction learning.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Thomas KruckerDepartments of Neuropharmacology and Molecular Biology, The Scripps Research Institute, La Jolla, California 92037, USA.
George R Siggins
Robert K McNamara
Kristen A Lindsley
Alan Dao
David W Allison
Luis De Lecea
Timothy W Lovenberg
J Gregor Sutcliffe
Dan D Gerendasy
Scripps Research Institute · USUniversity of Pennsylvania · US

Funding

GENE EXPRESSION IN RAT BRAINR01GM032355 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI SUTCLIFFE, J GREGOR · 1985 to 2010
$4.2M
SOMATOSTATIN RELATED PEPTIDES AND BRAIN FUNCTIONR01MH044346 · NIMH · SCRIPPS RESEARCH INSTITUTE · PI SIGGINS, GEORGE ROBERT · 1999 to 2003
$1.1M
RC3--A POTENTIAL SWITCH FOR THE INDUCTION OF LTP AND LTDR01NS035831 · NINDS · SCRIPPS RESEARCH INSTITUTE · PI GERENDASY, DAN D. · 1997 to 2000
$289k
THE ROLE OF CYTOKINES IN THE PATHOGENESIS OF AIDS DEMENTIA COMPLEXP50MH047680 · NIMH · SCRIPPS RESEARCH INSTITUTE · PI BLOOM, FLOYD ELLIOTT · 1990 to 2000
$77k
SOMATOSTATIN AND BRAIN FUNCTIONR37MH044346 · NIMH · SCRIPPS RESEARCH INSTITUTE · PI SIGGINS, GEORGE ROBERT · 1988 to 1997
–
NIGMS NIH HHS GM32355NIGMS NIH HHS R01 GM032355NIMH NIH HHS MH44346NIMH NIH HHS MH47680NIMH NIH HHS R01 MH044346NINDS NIH HHS NS35831
6 · The paper itself

Abstract

We used homologous recombination in the mouse to knock-out RC3, a postsynaptic, calmodulin-binding PKC substrate. Mutant brains exhibited lower immunoreactivity to phospho-Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) but had the same synaptic density as wild type and did not exhibit a gross neuroanatomical phenotype. Basal excitatory synaptic transmission in CA1 was depressed, long-term potentiation (LTP) was enhanced, and the depressant effects of the metabotropic glutamate receptor (mGluR) agonist (RS)-3,5-dihydroxyphenylglycine was occluded compared with littermate controls. The frequency-response curve was displaced to the left, and long-term depression (LTD) could not be induced unless low-frequency stimuli were preceded by high-frequency tetani. Depotentiation was much more robust in the mutant, and only one stimulus was required to saturate LTD in primed mutant hippocampi, whereas multiple low-frequency stimuli were required in wild-type slices. Thus, ablation of RC3 appears to render the postsynaptic neuron hypersensitive to Ca(2+), decreasing its LTD and LTP thresholds and accentuating the effects of priming stimuli. We propose an mGluR-dependent CaM-based sliding threshold mechanism for metaplasticity that is governed by the phosphorylation states of RC3 and CaMKII.

Indexed as

Neuronal PlasticityAnimalsCalcium-Calmodulin-Dependent Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase Type 2CalmodulinCalmodulin-Binding ProteinsCells, CulturedExcitatory Postsynaptic PotentialsGene TargetingHippocampusKineticsLong-Term PotentiationMiceMice, Inbred C57BLMice, KnockoutModels, NeurologicalCalcium-Calmodulin-Dependent Protein KinasesCalcium-Calmodulin-Dependent Protein Kinase Type 2CalmodulinCalmodulin-Binding ProteinsNerve Tissue ProteinsNeurograninNrgn protein, mouseReceptors, Metabotropic Glutamate

Identifiers

PMID12097504
PMCPMC6758189
OpenAlexW2163883777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.